The Challenges of Dual Product Use

Wednesday, August 15, 2012: 3:00 PM
2503A (Kansas City Convention Center)
Dr. Pamela Ling, MD MPH , University of California San Francisco, San Francisco, CA
Dr. Frank Chaloupka, Ph.D , University of Illinois at Chicago: Institute for Health Research and Policy, Chicago, IL
Dr. Herb Severson, PhD , Oregon Research Institute, Eugene, OR

Learning Objectives

At the conclusion of this presentation attendees will be able to:

  1. Outline the patterns and predictors of dual use
  2. Give an example of how the tobacco industry is promoting its product
  3. Explain the addiction, cessation, public health, and policy implications of dual use

Cross Cutting Program Area(s): Tobacco Control Policies and Tobacco Industry

· Audience: Tobacco control program administrators Researchers Cessation counselors Health policy makers · Key Points: Dual use of cigarettes and other tobacco products, particularly various forms of smokeless tobacco, appears to be increasing in the United States. That trend may be due in part to tobacco industry product development and marketing, although some advocates have been promoting non-cigarette tobacco products as part of a tobacco harm reduction strategy. Dual use of tobacco products may have major public health implications for nicotine addiction, smoking cessation, and health policy. · Educational Experience: This session will highlight recent studies on the magnitude and patterns of dual use of tobacco products and discuss tobacco industry efforts to promote concurrent usage of cigarettes and non-cigarette tobacco products. The effects of tobacco control policies and regulations on this pattern of tobacco use will be presented. Finally, this presentation will highlight the evidence for cessation strategies for persons who are addicted to multiple forms of tobacco products. · Benefits: Participants will gain a better understanding of the patterns and predictors of dual use, insight on how the tobacco industry may be promoting this pattern, and suggestions fort policy and clinical interventions that may be effective in addressing this emerging pattern of tobacco use.